Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome

The first controlled phase 3 trial of a genetic therapy for Dravet syndrome is now underway – with Phoenix Children's as one of 28 sites nationwide.

  • By

  • August 13, 2026

  • 4 min

Share

Original Source(s)

Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome

  • by

  • August 13, 2026

Related Content

Functional/dissociative seizures as a neuroenergetic deficit syndrome: a brain economy failure hypothesis

Clinical heterogeneity and diagnostic challenges in CASK-related neurodevelopmental disorders: a longitudinal observational study

Hidden labour of caregiving for persons with epilepsy in Limpopo and Mpumalanga provinces, South Africa: a qualitative study